Variant report
Variant | rs7209501 |
---|---|
Chromosome Location | chr17:43503294-43503295 |
allele | A/C |
Outlinks | Ensembl   UCSC |
- TF binding region (count:337)
- CpG islands (count:0)
- Chromatin interactive region (count:11)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | JUND | chr17:43503041-43503427 | K562 | blood: | n/a | n/a |
2 | CTCF | chr17:43503224-43503444 | GM12892 | blood: | n/a | chr17:43503316-43503334 chr17:43503318-43503331 |
3 | HDAC2 | chr17:43502887-43503471 | HepG2 | liver: | n/a | n/a |
4 | POLR2A | chr17:43502795-43503386 | Hela-S3 | cervix: | n/a | n/a |
5 | E2F4 | chr17:43502954-43503388 | MCF10A-Er-Src | breast: | n/a | n/a |
6 | CTCF | chr17:43503220-43503370 | GM12865 | blood: | n/a | chr17:43503316-43503334 chr17:43503318-43503331 |
7 | SMC3 | chr17:43503021-43503510 | Hela-S3 | cervix: | n/a | chr17:43503318-43503332 chr17:43503479-43503486 |
8 | FOS | chr17:43503007-43503426 | MCF10A-Er-Src | breast: | n/a | n/a |
9 | CTCF | chr17:43503264-43503382 | GM10248 | blood: | n/a | chr17:43503316-43503334 chr17:43503318-43503331 |
10 | MAX | chr17:43503246-43503468 | H1-hESC | embryonic stem cell: | n/a | n/a |
11 | RAD21 | chr17:43503024-43503492 | HepG2 | liver: | n/a | chr17:43503071-43503085 chr17:43503314-43503333 |
12 | RFX5 | chr17:43502912-43503442 | Hela-S3 | cervix: | n/a | n/a |
13 | FOSL2 | chr17:43502306-43503484 | HepG2 | liver: | n/a | chr17:43502516-43502526 chr17:43502516-43502525 chr17:43502517-43502526 |
14 | YY1 | chr17:43502772-43503551 | HepG2 | liver: | n/a | chr17:43503075-43503089 chr17:43502974-43502988 |
15 | MYC | chr17:43502956-43503445 | MCF10A-Er-Src | breast: | n/a | n/a |
16 | REST | chr17:43502615-43503511 | A549 | lung: | n/a | chr17:43503163-43503183 chr17:43503032-43503042 chr17:43502807-43502820 |
17 | CTCF | chr17:43503077-43503470 | MCF-7 | breast: | n/a | chr17:43503316-43503334 chr17:43503318-43503331 |
18 | CTCF | chr17:43503221-43503447 | MCF-7 | breast: | n/a | chr17:43503316-43503334 chr17:43503318-43503331 |
19 | MAX | chr17:43503231-43503471 | NB4 | blood: | n/a | n/a |
20 | MAFK | chr17:43503173-43503390 | K562 | blood: | n/a | n/a |
21 | CTCF | chr17:43503160-43503310 | K562 | blood: | n/a | n/a |
22 | CTCF | chr17:43503280-43503430 | SAEC | small airway: | n/a | chr17:43503316-43503334 chr17:43503318-43503331 |
23 | CTCF | chr17:43503229-43503430 | GM19239 | blood: | n/a | chr17:43503316-43503334 chr17:43503318-43503331 |
24 | NFYA | chr17:43503107-43503399 | Hela-S3 | cervix: | n/a | n/a |
25 | CTCF | chr17:43503220-43503370 | HCT-116 | colon: | n/a | chr17:43503316-43503334 chr17:43503318-43503331 |
26 | POLR2A | chr17:43502580-43503454 | H1-hESC | embryonic stem cell: | n/a | n/a |
27 | MAZ | chr17:43502804-43503496 | K562 | blood: | n/a | n/a |
28 | CHD2 | chr17:43502739-43503381 | Hela-S3 | cervix: | n/a | chr17:43502915-43502925 |
29 | MAX | chr17:43502946-43503454 | HepG2 | liver: | n/a | n/a |
30 | HCFC1 | chr17:43502255-43503570 | Hela-S3 | cervix: | n/a | n/a |
31 | CHD2 | chr17:43503106-43503464 | H1-hESC | embryonic stem cell: | n/a | n/a |
32 | CTCF | chr17:43503220-43503370 | HPAF | blood vessel: | n/a | chr17:43503316-43503334 chr17:43503318-43503331 |
33 | CTCF | chr17:43503200-43503350 | GM12874 | blood: | n/a | chr17:43503316-43503334 chr17:43503318-43503331 |
34 | CTCF | chr17:43503220-43503370 | HEK293 | kidney: | n/a | chr17:43503316-43503334 chr17:43503318-43503331 |
35 | POLR2A | chr17:43502673-43503507 | H1-hESC | embryonic stem cell: | n/a | n/a |
36 | CTCF | chr17:43503240-43503390 | HA-sp | spinal cord: | n/a | chr17:43503316-43503334 chr17:43503318-43503331 |
37 | ARID3A | chr17:43502923-43503439 | HepG2 | liver: | n/a | n/a |
38 | CTCF | chr17:43503173-43503494 | NHEK | skin: | n/a | chr17:43503316-43503334 chr17:43503318-43503331 |
39 | EP300 | chr17:43502454-43503350 | HepG2 | liver: | n/a | chr17:43503075-43503091 |
40 | CTCF | chr17:43503220-43503370 | GM12873 | blood: | n/a | chr17:43503316-43503334 chr17:43503318-43503331 |
41 | CTCF | chr17:43503100-43503512 | K562 | blood: | n/a | chr17:43503316-43503334 chr17:43503318-43503331 chr17:43503498-43503506 |
42 | MAX | chr17:43502601-43503679 | A549 | lung: | n/a | n/a |
43 | CTCF | chr17:43503220-43503370 | HepG2 | liver: | n/a | chr17:43503316-43503334 chr17:43503318-43503331 |
44 | ZNF143 | chr17:43503194-43503450 | K562 | blood: | n/a | n/a |
45 | RCOR1 | chr17:43502974-43503504 | HepG2 | liver: | n/a | n/a |
46 | CTCF | chr17:43503260-43503410 | HA-sp | spinal cord: | n/a | chr17:43503316-43503334 chr17:43503318-43503331 |
47 | STAT3 | chr17:43502835-43503316 | MCF10A-Er-Src | breast: | n/a | chr17:43503250-43503262 chr17:43502860-43502872 |
48 | CTCF | chr17:43503233-43503431 | ProgFib | skin: | n/a | chr17:43503316-43503334 chr17:43503318-43503331 |
49 | CTCF | chr17:43503220-43503370 | GM12878 | blood: | n/a | chr17:43503316-43503334 chr17:43503318-43503331 |
50 | CTCF | chr17:43503260-43503410 | HAc | cerebellar: | n/a | chr17:43503316-43503334 chr17:43503318-43503331 |
No data |
(count:11 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr17:43324524..43327061-chr17:43500908..43504321,4 | MCF-7 | breast: | |
2 | chr17:43471887..43473377-chr17:43502761..43503819,7 | MCF-7 | breast: | |
3 | chr17:43502180..43505047-chr17:43970966..43974065,3 | MCF-7 | breast: | |
4 | chr17:43487372..43488970-chr17:43502341..43504039,2 | MCF-7 | breast: | |
5 | chr17:43501715..43503974-chr17:43507657..43510348,3 | MCF-7 | breast: | |
6 | chr17:43213295..43214838-chr17:43501278..43504057,2 | MCF-7 | breast: | |
7 | chr17:43479466..43481863-chr17:43502551..43504495,2 | MCF-7 | breast: | |
8 | chr17:43485567..43488047-chr17:43501616..43504138,2 | MCF-7 | breast: | |
9 | chr17:43297580..43300347-chr17:43502925..43505246,3 | K562 | blood: | |
10 | chr17:43212320..43213240-chr17:43502405..43503725,3 | K562 | blood: | |
11 | chr1:45186798..45187678-chr17:43502939..43503458,2 | HCT-116 | colon: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ARHGAP27 | TF binding region |
ENSG00000267121 | Chromatin interaction |
ENSG00000199377 | Chromatin interaction |
ENSG00000186868 | Chromatin interaction |
ENSG00000264589 | Chromatin interaction |
ENSG00000267278 | Chromatin interaction |
ENSG00000184922 | Chromatin interaction |
ENSG00000233483 | Chromatin interaction |
ENSG00000181513 | Chromatin interaction |
ENSG00000159314 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs11012 | 0.91[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs1105569 | 1.00[ASN][1000 genomes] |
rs1105570 | 1.00[ASN][1000 genomes] |
rs1105571 | 1.00[ASN][1000 genomes] |
rs12452273 | 0.81[AMR][1000 genomes];0.89[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs12939187 | 0.84[AFR][1000 genomes];0.91[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs12940792 | 0.97[AMR][1000 genomes];0.95[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs12942666 | 0.97[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs12942951 | 0.93[AMR][1000 genomes];0.89[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs12946723 | 0.86[AMR][1000 genomes];0.93[EUR][1000 genomes] |
rs12946900 | 0.84[AFR][1000 genomes];0.91[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs12947718 | 0.91[AMR][1000 genomes];0.95[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs12949256 | 0.82[EUR][1000 genomes] |
rs12950965 | 0.90[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs12952504 | 0.95[AMR][1000 genomes];0.95[EUR][1000 genomes] |
rs12952764 | 0.97[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs1568949 | 1.00[ASN][1000 genomes] |
rs1568950 | 1.00[ASN][1000 genomes] |
rs1568951 | 1.00[ASN][1000 genomes] |
rs16940633 | 1.00[ASN][1000 genomes] |
rs1706748 | 1.00[ASN][1000 genomes] |
rs17631303 | 0.90[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs17631676 | 0.81[AMR][1000 genomes];0.95[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs17686610 | 1.00[ASN][1000 genomes] |
rs17687462 | 1.00[ASN][1000 genomes] |
rs17687504 | 1.00[ASN][1000 genomes] |
rs17687534 | 1.00[ASN][1000 genomes] |
rs17687571 | 1.00[ASN][1000 genomes] |
rs17687625 | 1.00[ASN][1000 genomes] |
rs17687667 | 1.00[ASN][1000 genomes] |
rs17687740 | 1.00[ASN][1000 genomes] |
rs17687838 | 1.00[ASN][1000 genomes] |
rs17687849 | 1.00[ASN][1000 genomes] |
rs17688002 | 1.00[ASN][1000 genomes] |
rs17688032 | 1.00[ASN][1000 genomes] |
rs17688056 | 1.00[ASN][1000 genomes] |
rs17688068 | 1.00[ASN][1000 genomes] |
rs17688090 | 1.00[ASN][1000 genomes] |
rs17688126 | 1.00[ASN][1000 genomes] |
rs17688205 | 1.00[ASN][1000 genomes] |
rs17688249 | 1.00[ASN][1000 genomes] |
rs17688296 | 1.00[ASN][1000 genomes] |
rs17688767 | 1.00[ASN][1000 genomes] |
rs17688773 | 1.00[ASN][1000 genomes] |
rs17688875 | 1.00[ASN][1000 genomes] |
rs17688916 | 1.00[ASN][1000 genomes] |
rs17688922 | 1.00[ASN][1000 genomes] |
rs17688944 | 1.00[ASN][1000 genomes] |
rs17689104 | 1.00[ASN][1000 genomes] |
rs17689116 | 1.00[ASN][1000 genomes] |
rs17689182 | 1.00[ASN][1000 genomes] |
rs17689218 | 1.00[ASN][1000 genomes] |
rs17760577 | 1.00[ASN][1000 genomes] |
rs17760631 | 1.00[ASN][1000 genomes] |
rs17760733 | 1.00[ASN][1000 genomes] |
rs17760817 | 1.00[ASN][1000 genomes] |
rs17761046 | 1.00[ASN][1000 genomes] |
rs17761100 | 1.00[ASN][1000 genomes] |
rs17761124 | 1.00[ASN][1000 genomes] |
rs17761207 | 1.00[ASN][1000 genomes] |
rs17761387 | 1.00[ASN][1000 genomes] |
rs17761581 | 1.00[ASN][1000 genomes] |
rs17762073 | 1.00[ASN][1000 genomes] |
rs17762165 | 1.00[ASN][1000 genomes] |
rs17762308 | 1.00[ASN][1000 genomes] |
rs17762361 | 1.00[ASN][1000 genomes] |
rs17762535 | 1.00[ASN][1000 genomes] |
rs1808189 | 0.87[EUR][1000 genomes] |
rs1879581 | 0.88[AMR][1000 genomes];0.97[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs1879582 | 1.00[ASN][1000 genomes] |
rs1879583 | 0.81[EUR][1000 genomes] |
rs1879585 | 0.91[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs1879586 | 1.00[ASN][1000 genomes] |
rs1880749 | 1.00[ASN][1000 genomes] |
rs1880750 | 1.00[ASN][1000 genomes] |
rs1971374 | 1.00[ASN][1000 genomes] |
rs2028078 | 0.83[AMR][1000 genomes];0.95[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2077606 | 0.84[AFR][1000 genomes];0.91[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2090847 | 0.90[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2139890 | 0.84[AFR][1000 genomes];0.88[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2253488 | 1.00[ASN][1000 genomes] |
rs241020 | 1.00[ASN][1000 genomes] |
rs241021 | 1.00[ASN][1000 genomes] |
rs241028 | 1.00[ASN][1000 genomes] |
rs241032 | 1.00[ASN][1000 genomes] |
rs241033 | 1.00[ASN][1000 genomes] |
rs241041 | 1.00[ASN][1000 genomes] |
rs2458179 | 1.00[ASN][1000 genomes] |
rs2458187 | 1.00[ASN][1000 genomes] |
rs2462835 | 1.00[ASN][1000 genomes] |
rs2463523 | 1.00[ASN][1000 genomes] |
rs2668644 | 1.00[ASN][1000 genomes] |
rs2684526 | 1.00[ASN][1000 genomes] |
rs2693359 | 1.00[ASN][1000 genomes] |
rs2693362 | 1.00[ASN][1000 genomes] |
rs2942164 | 1.00[ASN][1000 genomes] |
rs2942165 | 1.00[ASN][1000 genomes] |
rs2942166 | 1.00[ASN][1000 genomes] |
rs2942167 | 1.00[ASN][1000 genomes] |
rs2942168 | 1.00[ASN][1000 genomes] |
rs2942169 | 1.00[ASN][1000 genomes] |
rs2942170 | 1.00[ASN][1000 genomes] |
rs2959992 | 1.00[ASN][1000 genomes] |
rs2960000 | 0.88[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs3108317 | 1.00[ASN][1000 genomes] |
rs34018943 | 0.93[AFR][1000 genomes];0.91[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs34063617 | 0.93[AMR][1000 genomes];0.95[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs34104358 | 0.84[AFR][1000 genomes];0.91[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs3418 | 1.00[ASN][1000 genomes] |
rs34286926 | 0.97[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs34363898 | 0.84[AFR][1000 genomes];0.91[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs34465449 | 0.91[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs34792542 | 0.81[AMR][1000 genomes];0.83[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs34887474 | 0.84[AFR][1000 genomes];0.91[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs34915103 | 0.97[AMR][1000 genomes];0.95[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs35327136 | 0.82[AMR][1000 genomes];0.96[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs35389313 | 0.88[AMR][1000 genomes];0.94[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs35489312 | 0.90[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs35519908 | 0.97[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs35626715 | 0.97[AMR][1000 genomes];0.97[EUR][1000 genomes] |
rs35884427 | 0.97[AMR][1000 genomes];0.95[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs36078910 | 0.88[AMR][1000 genomes];0.95[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs36114997 | 0.90[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs365825 | 1.00[ASN][1000 genomes] |
rs383241 | 1.00[ASN][1000 genomes] |
rs385691 | 1.00[ASN][1000 genomes] |
rs389217 | 1.00[ASN][1000 genomes] |
rs389978 | 1.00[ASN][1000 genomes] |
rs392116 | 1.00[ASN][1000 genomes] |
rs393152 | 1.00[ASN][1000 genomes] |
rs393675 | 1.00[ASN][1000 genomes] |
rs393838 | 1.00[ASN][1000 genomes] |
rs3946526 | 0.86[AMR][1000 genomes];0.96[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs396593 | 1.00[ASN][1000 genomes] |
rs3972613 | 1.00[ASN][1000 genomes] |
rs413778 | 1.00[ASN][1000 genomes] |
rs413917 | 1.00[ASN][1000 genomes] |
rs422112 | 1.00[ASN][1000 genomes] |
rs424243 | 1.00[ASN][1000 genomes] |
rs434428 | 1.00[ASN][1000 genomes] |
rs434598 | 1.00[ASN][1000 genomes] |
rs434805 | 1.00[ASN][1000 genomes] |
rs434971 | 1.00[ASN][1000 genomes] |
rs439558 | 1.00[ASN][1000 genomes] |
rs4479288 | 1.00[ASN][1000 genomes] |
rs4479289 | 1.00[ASN][1000 genomes] |
rs448830 | 1.00[ASN][1000 genomes] |
rs4605208 | 1.00[ASN][1000 genomes] |
rs4609898 | 1.00[ASN][1000 genomes] |
rs4763 | 0.85[AMR][1000 genomes];0.90[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs5026246 | 1.00[ASN][1000 genomes] |
rs55642947 | 0.90[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs55643511 | 0.81[AMR][1000 genomes];0.93[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs55648326 | 0.90[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs55651627 | 1.00[ASN][1000 genomes] |
rs55652155 | 0.81[AMR][1000 genomes];0.94[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs55653963 | 1.00[ASN][1000 genomes] |
rs55663797 | 0.88[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs55669046 | 1.00[ASN][1000 genomes] |
rs55671319 | 0.94[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs55688739 | 1.00[ASN][1000 genomes] |
rs55703888 | 0.84[AFR][1000 genomes];0.91[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs55746869 | 0.91[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs55787734 | 1.00[ASN][1000 genomes] |
rs55790407 | 0.91[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs55793500 | 0.83[AMR][1000 genomes];0.94[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs55849973 | 1.00[ASN][1000 genomes] |
rs55896111 | 1.00[ASN][1000 genomes] |
rs55914643 | 0.93[AMR][1000 genomes];0.95[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs55925547 | 0.92[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs55962674 | 1.00[ASN][1000 genomes] |
rs55972157 | 1.00[ASN][1000 genomes] |
rs55973918 | 1.00[ASN][1000 genomes] |
rs55974014 | 1.00[ASN][1000 genomes] |
rs55980621 | 1.00[ASN][1000 genomes] |
rs55989971 | 1.00[ASN][1000 genomes] |
rs56005713 | 0.84[AFR][1000 genomes];0.91[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs56015792 | 0.81[AMR][1000 genomes];0.95[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs56020833 | 0.88[AMR][1000 genomes];0.98[EUR][1000 genomes] |
rs56046792 | 1.00[ASN][1000 genomes] |
rs56062621 | 1.00[ASN][1000 genomes] |
rs56100013 | 1.00[ASN][1000 genomes] |
rs56110538 | 1.00[ASN][1000 genomes] |
rs56159231 | 0.88[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs56160448 | 1.00[ASN][1000 genomes] |
rs56167344 | 1.00[ASN][1000 genomes] |
rs56167560 | 1.00[ASN][1000 genomes] |
rs56168933 | 0.90[AMR][1000 genomes];0.97[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs56192752 | 0.81[AMR][1000 genomes];0.93[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs56212100 | 0.97[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs56220242 | 1.00[ASN][1000 genomes] |
rs56220387 | 0.83[AMR][1000 genomes];0.95[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs56236914 | 0.82[AMR][1000 genomes];0.94[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs56323722 | 1.00[ASN][1000 genomes] |
rs56323832 | 1.00[ASN][1000 genomes] |
rs56328224 | 1.00[ASN][1000 genomes] |
rs56378631 | 0.97[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs56397077 | 1.00[ASN][1000 genomes] |
rs56400821 | 1.00[ASN][1000 genomes] |
rs56406407 | 1.00[ASN][1000 genomes] |
rs593720 | 1.00[ASN][1000 genomes] |
rs61667602 | 1.00[ASN][1000 genomes] |
rs62053939 | 1.00[ASN][1000 genomes] |
rs62053940 | 1.00[ASN][1000 genomes] |
rs62053943 | 1.00[ASN][1000 genomes] |
rs62053945 | 1.00[ASN][1000 genomes] |
rs62053946 | 1.00[ASN][1000 genomes] |
rs62053947 | 1.00[ASN][1000 genomes] |
rs62053948 | 1.00[ASN][1000 genomes] |
rs62053949 | 1.00[ASN][1000 genomes] |
rs62053950 | 1.00[ASN][1000 genomes] |
rs62053951 | 1.00[ASN][1000 genomes] |
rs62053952 | 1.00[ASN][1000 genomes] |
rs62053953 | 1.00[ASN][1000 genomes] |
rs62053954 | 1.00[ASN][1000 genomes] |
rs62053955 | 1.00[ASN][1000 genomes] |
rs62053956 | 1.00[ASN][1000 genomes] |
rs62053957 | 1.00[ASN][1000 genomes] |
rs62053958 | 1.00[ASN][1000 genomes] |
rs62053959 | 1.00[ASN][1000 genomes] |
rs62054372 | 1.00[ASN][1000 genomes] |
rs62054378 | 1.00[ASN][1000 genomes] |
rs62055660 | 1.00[ASN][1000 genomes] |
rs62055661 | 1.00[ASN][1000 genomes] |
rs62055662 | 1.00[ASN][1000 genomes] |
rs62055663 | 1.00[ASN][1000 genomes] |
rs62055664 | 1.00[ASN][1000 genomes] |
rs62055665 | 1.00[ASN][1000 genomes] |
rs62055689 | 1.00[ASN][1000 genomes] |
rs62055691 | 1.00[ASN][1000 genomes] |
rs62055692 | 1.00[ASN][1000 genomes] |
rs62055693 | 1.00[ASN][1000 genomes] |
rs62055696 | 1.00[ASN][1000 genomes] |
rs62055697 | 1.00[ASN][1000 genomes] |
rs62055698 | 1.00[ASN][1000 genomes] |
rs62055700 | 1.00[ASN][1000 genomes] |
rs62055701 | 1.00[ASN][1000 genomes] |
rs62055702 | 1.00[ASN][1000 genomes] |
rs62055704 | 1.00[ASN][1000 genomes] |
rs62055705 | 1.00[ASN][1000 genomes] |
rs62055707 | 1.00[ASN][1000 genomes] |
rs62055708 | 1.00[ASN][1000 genomes] |
rs62055709 | 1.00[ASN][1000 genomes] |
rs62055710 | 1.00[ASN][1000 genomes] |
rs62055712 | 1.00[ASN][1000 genomes] |
rs62055713 | 1.00[ASN][1000 genomes] |
rs62055714 | 1.00[ASN][1000 genomes] |
rs62055715 | 1.00[ASN][1000 genomes] |
rs62055716 | 1.00[ASN][1000 genomes] |
rs62055717 | 1.00[ASN][1000 genomes] |
rs62055751 | 1.00[ASN][1000 genomes] |
rs62055752 | 1.00[ASN][1000 genomes] |
rs62055753 | 1.00[ASN][1000 genomes] |
rs62055754 | 1.00[ASN][1000 genomes] |
rs62056874 | 1.00[ASN][1000 genomes] |
rs62056875 | 1.00[ASN][1000 genomes] |
rs62056876 | 1.00[ASN][1000 genomes] |
rs62056877 | 1.00[ASN][1000 genomes] |
rs62056878 | 1.00[ASN][1000 genomes] |
rs62056879 | 1.00[ASN][1000 genomes] |
rs62056880 | 1.00[ASN][1000 genomes] |
rs62056881 | 1.00[ASN][1000 genomes] |
rs62056905 | 1.00[ASN][1000 genomes] |
rs62056906 | 1.00[ASN][1000 genomes] |
rs62056908 | 1.00[ASN][1000 genomes] |
rs62056909 | 1.00[ASN][1000 genomes] |
rs62056910 | 1.00[ASN][1000 genomes] |
rs62056911 | 1.00[ASN][1000 genomes] |
rs62056912 | 1.00[ASN][1000 genomes] |
rs62056913 | 1.00[ASN][1000 genomes] |
rs62056915 | 1.00[ASN][1000 genomes] |
rs62056916 | 1.00[ASN][1000 genomes] |
rs62056917 | 1.00[ASN][1000 genomes] |
rs62056918 | 1.00[ASN][1000 genomes] |
rs62056919 | 1.00[ASN][1000 genomes] |
rs62056920 | 1.00[ASN][1000 genomes] |
rs62056921 | 1.00[ASN][1000 genomes] |
rs62056922 | 1.00[ASN][1000 genomes] |
rs62056925 | 1.00[ASN][1000 genomes] |
rs62056926 | 1.00[ASN][1000 genomes] |
rs62056927 | 1.00[ASN][1000 genomes] |
rs62056928 | 1.00[ASN][1000 genomes] |
rs62056929 | 1.00[ASN][1000 genomes] |
rs62056930 | 1.00[ASN][1000 genomes] |
rs62056931 | 1.00[ASN][1000 genomes] |
rs62056932 | 1.00[ASN][1000 genomes] |
rs62056933 | 1.00[ASN][1000 genomes] |
rs62056934 | 1.00[ASN][1000 genomes] |
rs62056935 | 1.00[ASN][1000 genomes] |
rs62056936 | 1.00[ASN][1000 genomes] |
rs62056937 | 1.00[ASN][1000 genomes] |
rs62056939 | 1.00[ASN][1000 genomes] |
rs62056940 | 1.00[ASN][1000 genomes] |
rs62056946 | 1.00[ASN][1000 genomes] |
rs62064364 | 1.00[ASN][1000 genomes] |
rs62064597 | 0.83[AMR][1000 genomes];0.92[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62064598 | 0.80[AMR][1000 genomes];0.94[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62064600 | 0.80[AMR][1000 genomes];0.94[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62064603 | 0.80[AMR][1000 genomes];0.94[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62064637 | 0.82[AMR][1000 genomes];0.94[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62064641 | 0.88[AMR][1000 genomes];0.95[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62064643 | 0.86[AMR][1000 genomes];0.96[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62064645 | 0.90[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62064646 | 0.90[AMR][1000 genomes];0.99[EUR][1000 genomes] |
rs62064647 | 0.97[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62064649 | 0.97[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62064651 | 0.90[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs62064652 | 0.86[AMR][1000 genomes];0.91[EUR][1000 genomes] |
rs62064653 | 0.84[AFR][1000 genomes];0.90[AMR][1000 genomes];0.97[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62064654 | 0.90[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62064655 | 0.91[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62064657 | 0.90[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62065374 | 0.90[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62065376 | 0.90[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62065377 | 0.91[AMR][1000 genomes];0.91[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62065378 | 0.84[AFR][1000 genomes];0.91[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62065379 | 0.90[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62065380 | 0.90[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62065385 | 0.90[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62065389 | 0.85[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62065391 | 0.84[AFR][1000 genomes];0.86[AMR][1000 genomes];0.96[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62065392 | 0.86[AMR][1000 genomes];0.97[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62065393 | 1.00[ASN][1000 genomes] |
rs62065399 | 0.86[AMR][1000 genomes];0.97[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62065403 | 0.81[AMR][1000 genomes];0.94[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62065404 | 0.81[AMR][1000 genomes];0.95[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62065436 | 0.93[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62065437 | 0.81[AMR][1000 genomes];0.93[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62065438 | 0.93[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62065441 | 0.82[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62065442 | 0.91[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62065444 | 0.83[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62065445 | 0.91[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62065447 | 0.87[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62065448 | 0.88[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62065449 | 0.87[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62065452 | 1.00[ASN][1000 genomes] |
rs62065453 | 1.00[ASN][1000 genomes] |
rs62065459 | 1.00[ASN][1000 genomes] |
rs62066128 | 1.00[ASN][1000 genomes] |
rs62066460 | 1.00[ASN][1000 genomes] |
rs71238846 | 0.81[AMR][1000 genomes];0.95[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs71373560 | 0.90[AMR][1000 genomes];0.90[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs71373572 | 0.84[AFR][1000 genomes];0.91[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs7220206 | 0.91[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs7222389 | 0.97[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs7222444 | 0.88[AMR][1000 genomes];0.97[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs73984391 | 0.94[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs7502718 | 1.00[ASN][1000 genomes] |
rs7502937 | 1.00[ASN][1000 genomes] |
rs8071011 | 0.88[AMR][1000 genomes];0.95[EUR][1000 genomes] |
rs9730 | 0.84[AFR][1000 genomes];0.91[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
Variant overlapped rSNPs/rCNVs (count:48 , 50 per page) page:
1
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv431632 | chr17:43199763-43733983 | Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Strong transcription Enhancers Genic enhancers Transcr. at gene 5' and 3' Active TSS Bivalent/Poised TSS Bivalent Enhancer ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 210 gene(s) | inside rSNPs | diseases |
2 | nsv431633 | chr17:43199763-43772540 | Enhancers Flanking Active TSS Strong transcription Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' Weak transcription Active TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 210 gene(s) | inside rSNPs | diseases |
3 | nsv431634 | chr17:43346980-43659975 | Weak transcription Active TSS Enhancers Genic enhancers Strong transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 56 gene(s) | inside rSNPs | diseases |
4 | nsv431636 | chr17:43403005-43659881 | Active TSS Genic enhancers Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats Flanking Active TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 39 gene(s) | inside rSNPs | diseases |
5 | esv2754858 | chr17:43403005-43666906 | Weak transcription Flanking Bivalent TSS/Enh Enhancers Genic enhancers Transcr. at gene 5' and 3' Flanking Active TSS Bivalent Enhancer Active TSS Strong transcription ZNF genes & repeats Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 44 gene(s) | inside rSNPs | diseases |
6 | nsv431637 | chr17:43403005-43716885 | Genic enhancers Strong transcription Enhancers Flanking Active TSS Weak transcription Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 49 gene(s) | inside rSNPs | diseases |
7 | nsv428342 | chr17:43443554-43651084 | Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Active TSS Strong transcription Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 32 gene(s) | inside rSNPs | diseases |
8 | esv2757659 | chr17:43457886-43733983 | Enhancers Flanking Active TSS Genic enhancers Strong transcription Active TSS Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 45 gene(s) | inside rSNPs | diseases |
9 | esv2758691 | chr17:43457886-43816023 | Enhancers Flanking Active TSS Genic enhancers Active TSS Weak transcription Strong transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 47 gene(s) | inside rSNPs | diseases |
10 | esv2755280 | chr17:43459697-43666906 | Strong transcription Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription Transcr. at gene 5' and 3' Bivalent/Poised TSS Genic enhancers ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 40 gene(s) | inside rSNPs | diseases |
11 | nsv908304 | chr17:43467025-43524511 | Enhancers Genic enhancers Flanking Active TSS Strong transcription Bivalent Enhancer Weak transcription Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNA | 20 gene(s) | inside rSNPs | diseases |
12 | nsv1065930 | chr17:43467291-44151468 | Weak transcription Active TSS Bivalent/Poised TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Strong transcription Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 51 gene(s) | inside rSNPs | diseases |
13 | nsv431638 | chr17:43470156-43693538 | Strong transcription Enhancers Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 41 gene(s) | inside rSNPs | diseases |
14 | esv2755741 | chr17:43470760-43655688 | Bivalent/Poised TSS Strong transcription Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Genic enhancers Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 32 gene(s) | inside rSNPs | diseases |
15 | nsv431639 | chr17:43470760-43659355 | Bivalent Enhancer Enhancers Weak transcription Genic enhancers Active TSS Flanking Active TSS Strong transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 32 gene(s) | inside rSNPs | diseases |
16 | esv2754089 | chr17:43470760-43659881 | Enhancers Weak transcription Active TSS Genic enhancers Strong transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 33 gene(s) | inside rSNPs | diseases |
17 | esv34266 | chr17:43470760-43659975 | Enhancers Weak transcription Active TSS Strong transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Active TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 33 gene(s) | inside rSNPs | diseases |
18 | esv34577 | chr17:43470760-43659975 | Genic enhancers Weak transcription Bivalent/Poised TSS Strong transcription Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 33 gene(s) | inside rSNPs | diseases |
19 | esv2752564 | chr17:43470760-43659975 | Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 33 gene(s) | inside rSNPs | diseases |
20 | esv2753343 | chr17:43470760-43659975 | Enhancers Bivalent Enhancer Strong transcription Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 33 gene(s) | inside rSNPs | diseases |
21 | esv2753852 | chr17:43470760-43659975 | Active TSS Strong transcription Flanking Bivalent TSS/Enh Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 33 gene(s) | inside rSNPs | diseases |
22 | esv2754692 | chr17:43470760-43659975 | Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Strong transcription Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 33 gene(s) | inside rSNPs | diseases |
23 | esv2754773 | chr17:43470760-43659975 | Strong transcription Bivalent Enhancer Enhancers Genic enhancers Weak transcription Flanking Active TSS Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 33 gene(s) | inside rSNPs | diseases |
24 | esv2754821 | chr17:43470760-43659975 | Genic enhancers Strong transcription Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 33 gene(s) | inside rSNPs | diseases |
25 | esv2755261 | chr17:43470760-43659975 | Flanking Bivalent TSS/Enh Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS Bivalent Enhancer Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 33 gene(s) | inside rSNPs | diseases |
26 | esv2755434 | chr17:43470760-43659975 | Strong transcription Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Genic enhancers ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 33 gene(s) | inside rSNPs | diseases |
27 | esv2755618 | chr17:43470760-43659975 | Enhancers Flanking Active TSS Weak transcription Strong transcription Active TSS Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 33 gene(s) | inside rSNPs | diseases |
28 | esv2756206 | chr17:43470760-43659975 | Flanking Active TSS Weak transcription Enhancers Active TSS Strong transcription Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 33 gene(s) | inside rSNPs | diseases |
29 | esv2756211 | chr17:43470760-43659975 | Bivalent/Poised TSS Active TSS Strong transcription Flanking Active TSS Enhancers Weak transcription Genic enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 33 gene(s) | inside rSNPs | diseases |
30 | esv2756238 | chr17:43470760-43659975 | Weak transcription Strong transcription Genic enhancers Enhancers Bivalent Enhancer Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 33 gene(s) | inside rSNPs | diseases |
31 | esv2756640 | chr17:43470760-43659975 | Flanking Active TSS Genic enhancers Strong transcription Weak transcription Enhancers Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 33 gene(s) | inside rSNPs | diseases |
32 | esv34307 | chr17:43470760-43666906 | Enhancers Genic enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Strong transcription Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 38 gene(s) | inside rSNPs | diseases |
33 | esv2755466 | chr17:43470760-43666906 | Enhancers Flanking Active TSS Active TSS Weak transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' Genic enhancers Strong transcription Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 38 gene(s) | inside rSNPs | diseases |
34 | esv2756448 | chr17:43470760-43666906 | Weak transcription Strong transcription Enhancers Flanking Active TSS Bivalent Enhancer Active TSS Genic enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 38 gene(s) | inside rSNPs | diseases |
35 | nsv431640 | chr17:43470760-43666906 | Weak transcription Enhancers Active TSS Genic enhancers Flanking Bivalent TSS/Enh Strong transcription Flanking Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 38 gene(s) | inside rSNPs | diseases |
36 | esv2753768 | chr17:43470760-43734304 | Weak transcription Enhancers Flanking Bivalent TSS/Enh Strong transcription Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Genic enhancers Bivalent/Poised TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 43 gene(s) | inside rSNPs | diseases |
37 | esv2754725 | chr17:43470760-43741452 | Flanking Active TSS Strong transcription Enhancers Genic enhancers Weak transcription Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 43 gene(s) | inside rSNPs | diseases |
38 | esv2752397 | chr17:43485791-43659975 | Enhancers Strong transcription Weak transcription Flanking Active TSS Bivalent Enhancer Genic enhancers Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 31 gene(s) | inside rSNPs | diseases |
39 | esv2753431 | chr17:43485791-43659975 | Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Strong transcription Bivalent Enhancer Genic enhancers Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 31 gene(s) | inside rSNPs | diseases |
40 | esv2755266 | chr17:43485791-43659975 | Weak transcription Flanking Active TSS Enhancers Strong transcription Active TSS Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 31 gene(s) | inside rSNPs | diseases |
41 | esv2755477 | chr17:43485791-43659975 | Enhancers Strong transcription Weak transcription Bivalent/Poised TSS Active TSS Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 31 gene(s) | inside rSNPs | diseases |
42 | esv2755480 | chr17:43485791-43659975 | Weak transcription Strong transcription Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 31 gene(s) | inside rSNPs | diseases |
43 | esv2756392 | chr17:43485791-43659975 | Enhancers Genic enhancers Weak transcription Active TSS Flanking Active TSS Strong transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 31 gene(s) | inside rSNPs | diseases |
44 | nsv431641 | chr17:43485791-43659975 | Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS Genic enhancers Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 31 gene(s) | inside rSNPs | diseases |
45 | esv35084 | chr17:43485791-43666906 | Flanking Bivalent TSS/Enh Weak transcription Active TSS Enhancers Bivalent/Poised TSS Strong transcription Genic enhancers Transcr. at gene 5' and 3' Flanking Active TSS Bivalent Enhancer ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 36 gene(s) | inside rSNPs | diseases |
46 | esv2754833 | chr17:43485791-43666906 | Transcr. at gene 5' and 3' Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Strong transcription Genic enhancers Bivalent/Poised TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 36 gene(s) | inside rSNPs | diseases |
47 | nsv431643 | chr17:43485791-43666906 | Enhancers Bivalent/Poised TSS Strong transcription Active TSS Weak transcription Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 36 gene(s) | inside rSNPs | diseases |
48 | nsv431642 | chr17:43485791-43716885 | Strong transcription Active TSS Weak transcription Enhancers Flanking Active TSS Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 41 gene(s) | inside rSNPs | diseases |
SNP | Gene | Cis/trans | Tissue | Source |
---|---|---|---|---|
rs7209501 | LRRC37A4 | cis | multi-tissue | Pritchard |
rs7209501 | ARHGAP27 | Cis_1M | lymphoblastoid | RTeQTL |
rs7209501 | LOC644246 | Cis_1M | lymphoblastoid | RTeQTL |
rs7209501 | ARL17 | Cis_1M | lymphoblastoid | RTeQTL |
rs7209501 | MAPK8IP1 | trans | lymphoblastoid | RTeQTL |
rs7209501 | LRRC37A4 | Cis_1M | lymphoblastoid | RTeQTL |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:43488800-43505400 | Weak transcription | Primary T cells effector/memory enriched fromperipheralblood | blood |
2 | chr17:43489600-43505400 | Weak transcription | Brain Hippocampus Middle | brain |
3 | chr17:43490200-43505600 | Weak transcription | Thymus | Thymus |
4 | chr17:43493200-43503800 | Weak transcription | Spleen | Spleen |
5 | chr17:43496600-43505800 | Weak transcription | Primary mononuclear cells fromperipheralblood | Blood |
6 | chr17:43501000-43503600 | Active TSS | Colonic Mucosa | Colon |
7 | chr17:43501400-43503400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
8 | chr17:43501400-43504200 | Enhancers | Primary monocytes fromperipheralblood | blood |
9 | chr17:43501800-43504000 | Enhancers | Placenta Amnion | Placenta Amnion |
10 | chr17:43502000-43503400 | Active TSS | A549 | lung |
11 | chr17:43502000-43503800 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
12 | chr17:43502200-43503400 | Active TSS | HUES6 Cell Line | embryonic stem cell |
13 | chr17:43502200-43503400 | Flanking Active TSS | Foreskin Keratinocyte Primary Cells skin02 | Skin |
14 | chr17:43502200-43503400 | Flanking Active TSS | Foreskin Keratinocyte Primary Cells skin03 | Skin |
15 | chr17:43502200-43503400 | Flanking Active TSS | NHEK | skin |
16 | chr17:43502200-43503800 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
17 | chr17:43502400-43503400 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
18 | chr17:43502400-43503400 | Active TSS | H9 Cell Line | embryonic stem cell |
19 | chr17:43502400-43503400 | Active TSS | HUES64 Cell Line | embryonic stem cell |
20 | chr17:43502400-43508000 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
21 | chr17:43502600-43503400 | Flanking Active TSS | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
22 | chr17:43502600-43503400 | Flanking Active TSS | Primary hematopoietic stem cells short term culture | blood |
23 | chr17:43502600-43503400 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
24 | chr17:43502600-43503400 | Enhancers | Liver | Liver |
25 | chr17:43502600-43503400 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |
26 | chr17:43502600-43503600 | Bivalent Enhancer | Foreskin Fibroblast Primary Cells skin01 | Skin |
27 | chr17:43502600-43503600 | Enhancers | Skeletal Muscle Male | skeletal muscle |
28 | chr17:43502600-43504000 | Bivalent Enhancer | Fetal Muscle Leg | muscle |
29 | chr17:43502600-43504200 | Enhancers | Primary neutrophils fromperipheralblood | blood |
30 | chr17:43502800-43503400 | Active TSS | ES-WA7 Cell Line | embryonic stem cell |
31 | chr17:43502800-43503400 | Active TSS | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
32 | chr17:43502800-43503400 | Active TSS | iPS-18 Cell Line | embryonic stem cell |
33 | chr17:43502800-43503400 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
34 | chr17:43502800-43503400 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
35 | chr17:43502800-43503400 | Active TSS | HepG2 | liver |
36 | chr17:43503000-43503400 | Active TSS | H1 Cell Line | embryonic stem cell |
37 | chr17:43503000-43503400 | Active TSS | H9 Derived Neuron Cultured Cells | ES cell derived |
38 | chr17:43503000-43503400 | Bivalent Enhancer | IMR90 fetal lung fibroblasts Cell Line | lung |
39 | chr17:43503000-43503400 | Active TSS | iPS-20b Cell Line | embryonic stem cell |
40 | chr17:43503000-43503400 | Flanking Active TSS | Right Ventricle | heart |
41 | chr17:43503000-43503600 | Enhancers | Duodenum Smooth Muscle | Duodenum |
42 | chr17:43503000-43503600 | Bivalent Enhancer | Fetal Stomach | stomach |
43 | chr17:43503000-43503600 | Enhancers | Stomach Mucosa | stomach |
44 | chr17:43503000-43503800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
45 | chr17:43503000-43503800 | Enhancers | Duodenum Mucosa | Duodenum |
46 | chr17:43503000-43503800 | Enhancers | Placenta | Placenta |
47 | chr17:43503000-43504200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
48 | chr17:43503000-43504200 | Enhancers | Adipose Nuclei | Adipose |
49 | chr17:43503000-43504200 | Enhancers | Fetal Intestine Small | intestine |
50 | chr17:43503000-43504200 | Weak transcription | Lung | lung |